We are international
Donate
TEXT SIZE   


Lenalidomide Inhibits the Multiple Myeloma Cell-Survival Factor IRF4/MUM1
By Antonia Lopez-Girona, M.D.
XIIth International Myeloma Workshop in Washington, DC
Antonia Lopez-Girona, M.D.
Celgene Corporation
02.23.09


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles